Analysis of the cost-effectiveness of an autotransfusion program in primary knee and hip replacement surgery;Análisis de la relación coste-efectividad de un programa de autotransfusión en cirugía protésica primaria de rodilla y cadera

Revista Espanola de Anestesiologia y Reanimacion

Volumn 46, Issue 9, 1999, Pages 396-403

  Diaz Espallardo C ^a   Moral Garcia V ^a  

^a Hospital Universitari Parc Taulí   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLOOD AUTOTRANSFUSION; CASE CONTROL STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HEALTH CARE QUALITY; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; MALE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION, AUTOLOGOUS; CASE-CONTROL STUDIES; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 0033219067     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion trasmited viral infection. N Engl J Med 1996; 334: 1.685-1.690.
2. Menitove JE. Transfusion-Transmitted Infection: Update. Semin Hematol 1996; 33: 290-301.
3. Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 1997: 34 (Supl 2): 34-40.
4. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS et al. Estimated risk of transfusion of the human immunodeficiency by screened blood in the United States. N Engl Med 1995; 333: 1.721-1.725.
5. Linden JV, Kaplan HS. Transfusion errors: cause and effects. Transfus Med Rev 1994; 8: 169-183.
6. Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion 1992; 32: 601-606.
7. Klein HG. Immunologic Aspects of Blood Transfusion. Semin Oncol 1994; 2: 16-20.
8. Landers DF, Hill GE, Wong KC, Fox IJ. Blood Transfusion-induced immunomodulation. Anesth Analg 1996; 82: 187-204.
9. Goldman M, Rémy-Prince S, Trépanier A, Décary F. Autologous donation error rates in Canada. Transfusion 1997; 37: 523-527.
10. Spence RK. Surgical Red Blood Cell Transfusion Practice Policies. Blood Management practice guidelines conference. Am J Surg 1995; 170 (Supl): 3-15.
11. Practice Guidelines for Blood Component Therapy. A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84: 732-747.
12. Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C et al. Cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332: 719-724.
13. Blumberg N, Kirkley SA, Heal JM. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery. Am J Surg 1996; 171: 324-330.
14. Gouezec H, Tardivel R, Danic B, Ballay JL, Malledant Y. Evalua ion of the cost of autologous erythrocyte concentrates in a hospital. Cah Anesthesiol 1996; 44: 451-454.
15. Roberts WA, Kirkley SA, Newby M. A cost comparison of allogeneic and preoperatively or intraoperatively donated autologous blood. Anesth Analg 1996; 83: 129-133.
16. Mercuriali F, Inghilleri G. Proposal of an algorithm to help the best transfusion strategy. Curr Med Res Opin 1996; 13: 465-478.
17. Olsfanger D, Fredman B, Goldstein B, Shapiro A, Jedeikin R. Acute normovolemic haemodilution decreases postoperative allogenic blood transfusion after total knee replacement. Br J Anaesth 1997; 79: 317-321.
18. Han CD, Shin DE. Postoperative blood salvage and reinfusion after total joint arthroplasty. J Arthoplasty 1997; 12: 511-516.
19. Goodnough LT, Monk TG, Brecher ME. Autologous blood procurement in the surgical setting: lessons learned in the Last 10 years. Vox Sang 1996; 71: 133-141.
20. Schmied H, Schiferer A, Sessler DI, Meznik C. The effects of red-cell scavenging, hemodilution, and active warming on allogenic blood requirements in patients undergoing hip or knee arthroplasty. Anesth Analg 1998; 86: 387-391.
21. Goodnough LT. Controversies in autologous blood procurement. Br J Anaesth 1998, 81 (Supl 1): 67-72.
22. Llau Pitarch JV, Sánchez de Merás AM. Práctica transfusional entre los anestesiólogos en España. Rev Esp Anestesiol Reanim 1998; 45: 226-232.
23. Audet AM, Andrzejewski C, Popovsky MA. Red blood cell transfusion practices in patients undergoing orthopedic surgery: a multi-institutional analysis. Orthopedics 1998; 21: 851-858.
24. Forgie MA, Wells PS, Laupacis A, Ferguson D. Preopcrative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med 1998; 158:610-616.
25. Knight JL, Sherer D, Guo J. Blood transfusion strategies for total knee arthroplasty: minimizing autologuos blood wastage, risk of homologous blood transfusion, and transfusion cost. J Arthroplasty 1998; 13: 70-76.
26. Borghi B, Pignotti E, Montebugnoli M, Bassi A, Corbascio MS, Elmar K et al. Autotransfusion in major orthopaedic surgery: experience with 1785 patients. Br J Anaesth 1997; 79: 662-664.
27. Goodnough LT, Brecher ME, Kanter MH, Aubuchon JP. Transfusion medicine. Second of two parts-blood transfusion. N Engl J Med 1999; 340: 525-533.
28. Goodnouhh LT, Mercuriali F. Compensatory erythropoiesis during autologous blood donation. Transfusion 1998 38: 613-615.
29. Hand GC, Henderson M, Mace P, Sherif N, Newman JH, Goldie DJ. Methyl methacrylate levels in unwashed salvage blood following unilateral total knee arthroplasty. J Arthoplasty 1998 13: 576-579.
30. Rizzi L, Bertacchi P, Ghezzi LM, Bellavista P, Scudeller G. Postoperative study on cost effectiveness in 161 patiens. Acta Orthop Scand 1998; 69: 31-34.
31. Adalberth G, Bystrom S, Kolstad K, Mallmin H, Milbrik J. Posoperative drainage of knee arthroplasty is not necessary: a randomized study of 90 patients. Acta Orthop Scand 1998; 69: 475-478.
32. Dalen T, Brostrom LA, Engstrom KG. Autotransfusion after total knee arthroplasty. Effects on blood cells, plasma chemistry, and whole blood rheology. J Arthoplasty 1997; 12: 517-525.
33. Ayers DC, Murray DG, Duerr DM. Blood salvage after total hip arthoplasty. J Bone Joint Surg Am 1995; 77: 1.347-1.351.
34. Goodnough LT, Brecher ME, Kanter MH, Aubuchon JP. Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 1999; 340: 438-447.
35. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE. Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee anhroplasty. J Bone Joint Surg Am 1999; 81: 2-10.
36. Churchill WH, McGurk S, Chapman RH, Wallace EL, Bertholf MF, Goodnough LT et al. The collaborative hospital transfusion study: variations in use of autologous blood account for hospital red cell use during primary hip and knee surgery. Transfusion 1998; 38: 530-539.
37. Larocque BJ, Gilbert K, Brien WF. A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty. Transfusion 1997; 37: 463-467.
38. Goodnough LT, Brecher ME. Autologous blood transfusion. Intern Med 1998; 37: 238-245.
39. Thomas MJ, Gillon J, Desmond MJ. Consensus Conference on autologous transfusion. Preoperative autologous donation. Transfusion 1996; 633-639.